These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24418926)

  • 1. Differences in clinical phenotype among patients with XP complementation group D: 3D structure and ATP-docking of XPD in silico.
    Nakano E; Ono R; Masaki T; Takeuchi S; Takaoka Y; Maeda E; Nishigori C
    J Invest Dermatol; 2014 Jun; 134(6):1775-1778. PubMed ID: 24418926
    [No Abstract]   [Full Text] [Related]  

  • 2. Human xeroderma pigmentosum group D gene encodes a DNA helicase.
    Sung P; Bailly V; Weber C; Thompson LH; Prakash L; Prakash S
    Nature; 1993 Oct; 365(6449):852-5. PubMed ID: 8413672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strict sun protection results in minimal skin changes in a patient with xeroderma pigmentosum and a novel c.2009delG mutation in XPD (ERCC2).
    Emmert S; Ueda T; Zumsteg U; Weber P; Khan SG; Oh KS; Boyle J; Laspe P; Zachmann K; Boeckmann L; Kuschal C; Bircher A; Kraemer KH
    Exp Dermatol; 2009 Jan; 18(1):64-8. PubMed ID: 18637129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
    Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
    Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene.
    Frederick GD; Amirkhan RH; Schultz RA; Friedberg EC
    Hum Mol Genet; 1994 Oct; 3(10):1783-8. PubMed ID: 7849702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
    Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
    Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of CAK complex accumulation at DNA damage sites in XP-B and XP-B/CS fibroblasts reveals differential regulation of CAK anchoring to core TFIIH by XPB and XPD helicases during nucleotide excision repair.
    Zhu Q; Wani G; Sharma N; Wani A
    DNA Repair (Amst); 2012 Dec; 11(12):942-50. PubMed ID: 23083890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes.
    Schäfer A; Gratchev A; Seebode C; Hofmann L; Schubert S; Laspe P; Apel A; Ohlenbusch A; Tzvetkov M; Weishaupt C; Oji V; Schön MP; Emmert S
    Exp Dermatol; 2013 Jul; 22(7):486-9. PubMed ID: 23800062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
    Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
    Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XPD helicase structures and activities: insights into the cancer and aging phenotypes from XPD mutations.
    Fan L; Fuss JO; Cheng QJ; Arvai AS; Hammel M; Roberts VA; Cooper PK; Tainer JA
    Cell; 2008 May; 133(5):789-800. PubMed ID: 18510924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D/Cockayne syndrome (XP-D/CS) cells.
    Vélez-Cruz R; Zadorin AS; Coin F; Egly JM
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):E212-20. PubMed ID: 23267107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes.
    Queille S; Drougard C; Sarasin A; Daya-Grosjean L
    J Invest Dermatol; 2001 Nov; 117(5):1162-70. PubMed ID: 11710928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome.
    Broughton BC; Thompson AF; Harcourt SA; Vermeulen W; Hoeijmakers JH; Botta E; Stefanini M; King MD; Weber CA; Cole J
    Am J Hum Genet; 1995 Jan; 56(1):167-74. PubMed ID: 7825573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rem mutations in the ATP-binding groove of the Rad3/XPD helicase lead to Xeroderma pigmentosum-Cockayne syndrome-like phenotypes.
    Herrera-Moyano E; Moriel-Carretero M; Montelone BA; Aguilera A
    PLoS Genet; 2014 Dec; 10(12):e1004859. PubMed ID: 25500814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both XPD alleles contribute to the phenotype of compound heterozygote xeroderma pigmentosum patients.
    Ueda T; Compe E; Catez P; Kraemer KH; Egly JM
    J Exp Med; 2009 Dec; 206(13):3031-46. PubMed ID: 19934020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype-specific adverse effects of XPD mutations on human prenatal development implicate impairment of TFIIH-mediated functions in placenta.
    Moslehi R; Kumar A; Mills JL; Ambroggio X; Signore C; Dzutsev A
    Eur J Hum Genet; 2012 Jun; 20(6):626-31. PubMed ID: 22234153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene.
    Broughton BC; Berneburg M; Fawcett H; Taylor EM; Arlett CF; Nardo T; Stefanini M; Menefee E; Price VH; Queille S; Sarasin A; Bohnert E; Krutmann J; Davidson R; Kraemer KH; Lehmann AR
    Hum Mol Genet; 2001 Oct; 10(22):2539-47. PubMed ID: 11709541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cancer-free phenotype in trichothiodystrophy is unrelated to its repair defect.
    Berneburg M; Clingen PH; Harcourt SA; Lowe JE; Taylor EM; Green MH; Krutmann J; Arlett CF; Lehmann AR
    Cancer Res; 2000 Jan; 60(2):431-8. PubMed ID: 10667598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.